Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-08-28 00:00:00 ET · period of report 2024-08-28 · accession 0001628280-24-038664 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-28 | 2024-08-28 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $2.48 | +5,000 | 752.7K | +0.7% | +$12.4K |
| D | 2024-08-28 | 2024-08-28 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $0.00 | -5,000 | 292.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-08-28 | M | A | 5,000 | $2.48 | 752,656 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-28 | M | D | 5,000 | $0.00 | 292,500 | D | $2.48 · — to 2030-12-30 | 5,000 Class A Common Stock | (F1) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |